By Tom Kerr, CFA
NASDAQ: DFNS
READ THE FULL DFNS RESEARCH REPORT
2nd Quarter 2026 Financial Results
On August 17, 2026, T3 Defense (NASDAQ: DFNS) filed its 10-Q for the period ending 6/30/26. For the quarter, revenues increased to $4.0 million, compared with no revenue in the prior year period. Gross profit was $1.0 million, which was a 25.4% gross margin, which was above our expectations. We believe that most of the company’s subsidiaries are profitable on an individual basis.
Operating expenses increased to $4.4 million, compared with $1.0 million in the year-ago period. The increase was primarily driven by $3.6 million in G&A expenses, with additional spending of $348,000 on R&D and $184,000 on sales and marketing.
Despite generating gross profit, the company reported a net loss of ($81.4) million, compared with net income of $3.0 million in the prior-year quarter. The significant loss was driven primarily by an $81.0 million loss from the change in fair value of stock purchase warrant liabilities, resulting in a net loss attributable to shareholders of ($82.5) million.
As of June 30, 2026, the Company had $21.2 million in current assets, including $4.1 million of cash and cash equivalents. Based on management’s current expectations, approximately $5.0 million will be required to fund operations over the next 12 months.
The company had negative working capital of approximately $131 million as of June 30, 2026, which was primarily driven by approximately $124 million of stock purchase warrant liabilities that do not require cash settlement.
Valuation
We believe T3 Defense can generate double-digit revenue growth over the next 10 years through organic growth and accretive acquisitions. We believe gross margins can reach the mid-to-high 30% range and, over the long term, approach 40%. Typically, Israeli defense companies have higher-than-industry-average gross margins due to a greater emphasis on software, sensors, and simulation technology rather than large-scale platform manufacturing. We believe EBITDA margins will be slightly positive in 2027 and grow significantly thereafter.
Our primary valuation tool utilizes a Discounted Cash Flow process. Under the scenario described above, we arrive at a target valuation of $100.00 per share. Our target price may be conservative as it incorporates a high discount rate of 12.5% due to the unpredictability of earnings, prevailing interest rates, and the timeline for reaching its margin goals on an annual basis. Also, this price target is based on the current portfolio of companies and does not take into account future acquisitions.
We also use forward price/sales multiples to validate our target price. The average 2027 price/sales multiple for small-cap & mid-cap defense companies based on 2027 revenue estimates is approximately 3.5x. That would provide a valuation in the range of $60.00-$70.00 per share for DFNS based on our 2027 revenue estimates.
We believe the company will reach cash flow breakeven at some point in calendar year 2027 and may not require additional funding to execute on its growth plans. However, it’s possible the company could access the capital markets to make important acquisitions.
The current market cap of only $15 million appears to be irrational and more reflective of the ongoing microcap stock malaise as opposed to company fundamentals.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives payments totaling a maximum fee of up to $50,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.